Agneta Siegbahn

Active 1988–2025

129
Papers
27,441
Citations
90
h-index
126
i10-index

Citations

Citations per year for Agneta Siegbahn1987: 1 citations1988: 11 citations1989: 18 citations1990: 23 citations1991: 22 citations1992: 26 citations1993: 29 citations1994: 64 citations1995: 64 citations1996: 83 citations1997: 84 citations1998: 125 citations1999: 181 citations2000: 165 citations2001: 159 citations2002: 144 citations2003: 189 citations2004: 206 citations2005: 139 citations2006: 161 citations2007: 154 citations2008: 124 citations2009: 119 citations2010: 106 citations2011: 107 citations2012: 119 citations2013: 143 citations2014: 188 citations2015: 214 citations2016: 290 citations2017: 285 citations2018: 240 citations2019: 751 citations2020: 738 citations2021: 824 citations2022: 556 citations2023: 430 citations2024: 706 citations2025: 282 citations2026: 20 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,879 citing papers, 21.1% of this breakdownUnited Kingdom: 1,236 citing papers, 9.1% of this breakdownChina: 1,053 citing papers, 7.7% of this breakdownGermany: 870 citing papers, 6.4% of this breakdownSweden: 752 citing papers, 5.5% of this breakdownItaly: 575 citing papers, 4.2% of this breakdownCanada: 538 citing papers, 4% of this breakdownNetherlands: 495 citing papers, 3.6% of this breakdownFrance: 428 citing papers, 3.2% of this breakdownAustralia: 367 citing papers, 2.7% of this breakdownDenmark: 363 citing papers, 2.7% of this breakdownJapan: 346 citing papers, 2.5% of this breakdown
0%21.1%Other 27.3%

Fields

  • Medicine57%
  • Biochemistry, Genetics and Molecular Biology31.3%
  • Immunology and Microbiology6.3%
  • Neuroscience1.7%
  • Nursing1%
  • Chemistry0.4%
  • Other2.3%

Topics

  • Genetic Associations and Epidemiology4.6%
  • Atrial Fibrillation Management and Outcomes3.8%
  • Angiogenesis and VEGF in Cancer3.2%
  • Antiplatelet Therapy and Cardiovascular Diseases2.7%
  • Adipokines, Inflammation, and Metabolic Diseases2.4%
  • Venous Thromboembolism Diagnosis and Management2.1%
  • Other81.2%

Coauthors

All papers

Open in search
  1. Genetics of circulating inflammatory proteins identifies drivers of immune-mediated disease risk and therapeutic targets

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Åsa Johansson, Ulf Gyllensten, Nick Powell, Oskar Hansson, Niklas Mattsson, Peter K. Joshi, John Danesh, Leonid Padyukov, Lars Klareskog, Mikael Landén, James F. Wilson, Agneta Siegbahn, Lars Wallentin, Anders Mälarstig, Adam S. Butterworth, James E. Peters - Nature Immunology 2023 cited by 729

  2. Discovery and refinement of loci associated with lipid levels

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Andrea Ganna, Nicholas Wainwright, Ci Song, Stefan Gustafsson, Andrea Ganna, Kathleen Stirrups, Manjinder S. Sandhu, Panos Deloukas, Cristina Pomilla, Stavroula Kanoni, Karen L Mohlke, Samia Mora, Inês Barroso, Daniel I Chasman, Samuli Ripatti, Nicholas W.J. Wainwright, Patrik K. E. Magnusson, Ci Song, Andrea Ganna, Nancy L. Pedersen, Karen L. Mohlke, Martin L. Buchkovich, Ying Wu, Alex S F Doney, Paul M. Ridker, Colin N A Palmer, Georg B Ehret, Paul M. Ridker, Aravinda Chakravarti, J. Beckmann, J. Beckmann, Hsing‐Yi Chang, Andres Metspalu, Cornelia M. van Duijn, Ayşe Demirkan, Peter J. Koudstaal, Heleen M. den Hertog, Evita G. van den Herik, Ross M Fraser, Louise A. Donnelly, Andrew D. Morris, Alex S. F. Doney, François Mach, Georg Ehret, Aravinda Chakravarti, Georg Ehret, Krista Fischer, Danish Saleheen, Kauko Heikkilä, Evelin Mihailov, Elina Hyppönen, Evelin Mihailov, Åsa Johansson, Ulf Gyllensten, Mary F. Feitosa, Ingrid B. Borecki, Patricia B Munroe, Cecilia M. Lindgren, Marjo-Riitta Järvelin, Teresa Ferreira, Igor Rudan, Jennifer L. Bolton, Sarah H. Wild, Jackie F. Price, James F. Wilson, Ross M. Fraser, Harry Campbell, Daniel F. Freitag, Cristina Pomilla, Danish Saleheen and 159 more - Nature Genetics 2013 cited by 3,287

  3. Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Sölve Elmståhl, Gunnar Engström, Eric B. Fauman, Céline Fernandez, Lude Franke, Paul W. Franks, Vilmantas Giedraitis, Chris Haley, Anders Hamsten, Andrés Ingason, Åsa Johansson, Peter K. Joshi, Lars Lind, Cecilia M. Lindgren, Steven A. Lubitz, Tom Palmer, Erin Macdonald-Dunlop, Martin Magnusson, Olle Melander, Karl Michaëlsson, Andrew P. Morris, Reedik Mägi, Michael W. Nagle, Peter M. Nilsson, Jan Nilsson, Marju Orho‐Melander, Ozren Polašek, Bram P. Prins, Erik Pålsson, Ting Qi, Marketa Sjögren, Johan Sundström, Praveen Surendran, Urmo Võsa, Thomas Werge, Rasmus Wernersson, Harm-Jan Westra, Jian Yang, Alexandra Zhernakova, Johan Ärnlöv, Jingyuan Fu, J. G. Smith, Tõnu Esko, Caroline Hayward, Ulf Gyllensten, Mikael Landén, Agneta Siegbahn, James F. Wilson, Lars Wallentin, Adam S. Butterworth, Michael V. Holmes, Erik Ingelsson, Anders Mälarstig - Nature Metabolism 2020 cited by 772

  4. The ABC (age, biomarkers, clinical history) stroke risk score: a biomarker-based risk score for predicting stroke in atrial fibrillation

    Authors: , , , , , , , , , , , , - European Heart Journal 2016 cited by 431

  5. Interleukin 6 and Cardiovascular Outcomes in Patients With Chronic Kidney Disease and Chronic Coronary Syndrome

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Vanina Gorosito, Ramiro Sánchez, David Brieger, Derek P. Chew, D. Cross, Ferdinandus J. de Looze, A. Farshid, Stephen Hall, Henry Krum, Geoff K Lane, Ernesto Oqueli Flores, John Stickland, Peter W Purnell, Gregory Szto, Peter L. Thompson, Jonathan Waites, Maged William, Christophe Beauloye, Jean Boland, Filip Charlier, Herbert JLP De Raedt, Joseph AY Dens, Karl Dujardin, Alain Friart, André Scheen, Erwin Schröder, Peter Sinnaeve, Stefan Verheye, Pascal Vranckx, JOSE ANTONIO ABRANTES, Denílson Campos de Albuquerque, Wilma Roberta Ardito, Luciano Baracioli, Marcelo Chiara Bertolami, Luiz Carlos Bodanese, Raúl D. Santos, Lília Nigro Maia, Euler RF Manenti, Roberto Luiz Marino, Clarisse Kaoru Ogawa Indio do Brasil, Maria Sanali de Oliveira Paiva, Álvaro Rabelo Alves, Salvador Rassi, Gilmar Reis, Paulo RF Rossi, José Francisco K Saraiva, Haralambi O Benov, Boryana Chompalova, Stefan Denchev, Assen Goudev, Valentina Grigorova, Atanas Mihov, Valentina M Mincheva, С. В. Петрова, Angelina Staneva, Dimitar Raev, S. Tisheva, Ronnie Aronson, Jacques Bédard, RAKESH BHARGAVA, David J. Borts, Christian Constance, Jean R. Cusson, Richard F. Davies, John Ducas, Murdo ER Ferguson, Ronald Goldenberg, François Grondin, Gábor Gyenes, Frank Halperin and 641 more - JAMA Cardiology 2021 cited by 111

  6. Plasma proteins associated with cardiovascular death in patients with chronic coronary heart disease: A retrospective study

    Authors: , , , , , , , , , , , , - PLoS Medicine 2021 cited by 124

  7. Bone morphogenetic protein 10: a novel risk marker of ischaemic stroke in patients with atrial fibrillation

    Authors: , , , , , , , , , , , , - European Heart Journal 2022 cited by 48

  8. Growth Differentiation Factor 15, a Marker of Oxidative Stress and Inflammation, for Risk Assessment in Patients With Atrial Fibrillation

    Authors: , , , , , , , , , , , - Circulation 2014 cited by 308

  9. Inflammatory Biomarkers Interleukin‐6 and C‐Reactive Protein and Outcomes in Stable Coronary Heart Disease: Experiences From the STABILITY (Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy) Trial

    Authors: , , , , , , , , , , , , , - Journal of the American Heart Association 2017 cited by 281

  10. Platelet-Specific PDGFB Ablation Impairs Tumor Vessel Integrity and Promotes Metastasis

    Authors: , , , , , , , , , , , , , , , , , , , - Cancer Research 2020 cited by 115

  11. Relationship Between Interleukin 6 and Mortality in Patients With Unstable Coronary Artery Disease

    Authors: , , , - JAMA 2001 cited by 557

  12. The novel biomarker-based ABC (age, biomarkers, clinical history)-bleeding risk score for patients with atrial fibrillation: a derivation and validation study

    Authors: , , , , , , , , , , , , , - The Lancet 2016 cited by 485

  13. Large-scale Metabolomic Profiling Identifies Novel Biomarkers for Incident Coronary Heart Disease

    Authors: , , , , , , , , , , , , , , - PLoS Genetics 2014 cited by 285

  14. Fibrin clot properties independently predict adverse clinical outcome following acute coronary syndrome: a PLATO substudy

    Authors: , , , , , , , , - European Heart Journal 2018 cited by 160

  15. N-Terminal Pro–B-Type Natriuretic Peptide for Risk Assessment in Patients With Atrial Fibrillation

    Authors: , , , , , , , , , , , , , , - Journal of the American College of Cardiology 2013 cited by 230

  16. Cardiac Biomarkers Are Associated With an Increased Risk of Stroke and Death in Patients With Atrial Fibrillation

    Authors: , , , , , , , , , , - Circulation 2012 cited by 398

  17. Biomarkers in atrial fibrillation: a clinical review

    Authors: , , , , - European Heart Journal 2013 cited by 298

  18. Antithrombotic therapy and body mass: an expert position paper of the ESC Working Group on Thrombosis

    Authors: , , , , , , , , , , , , , , , , , , , , , - European Heart Journal 2018 cited by 145

  19. Use of a proximity extension assay proteomics chip to discover new biomarkers for human atherosclerosis

    Authors: , , , , , - Atherosclerosis 2015 cited by 137

  20. Antiplatelet Agents for the Treatment and Prevention of Coronary Atherothrombosis

    Authors: , , , , , , , , , - Journal of the American College of Cardiology 2017 cited by 210

  21. Prediction of Residual Risk by Ceramide‐Phospholipid Score in Patients With Stable Coronary Heart Disease on Optimal Medical Therapy

    Authors: , , , , , , , , , , , , , - Journal of the American Heart Association 2020 cited by 64

  22. Biomarker-Based Risk Prediction With the ABC-AF Scores in Patients With Atrial Fibrillation Not Receiving Oral Anticoagulation

    Authors: , , , , , , , - Circulation 2021 cited by 48

  23. Different signal transduction properties of KDR and Flt1, two receptors for vascular endothelial growth factor.

    Authors: , , , , - Journal of Biological Chemistry 1994 cited by 1,665

  24. Growth differentiation factor-15 level predicts major bleeding and cardiovascular events in patients with acute coronary syndromes: results from the PLATO study

    Authors: , , , , , , , , , , - European Heart Journal 2015 cited by 183